[ad_1]
In the National Assembly on the 27th, the controversy over obtaining a new vaccine against coronavirus infection (Corona 19) was rekindled. President Roh Young-min, President Roh Young-min’s chief secretary, who attended the high-ranking party, the government and the governing council, said: “By February next year, vaccination of medical and health personnel will begin. the elders”. Ho-young Joo, who had requested a press conference beforehand, confronted her by insisting on the introduction of a ‘vaccine exchange between Korea and the United States’, saying, “Only sowing optimism can cause even greater misfortune.”
“We have already secured sufficient quantities to protect the Korean people in terms of the quantity of (safe vaccines),” said Mr. Roh, announcing plans to implement high-risk vaccines in February next year. “Each country will begin vaccinating the general population in the second quarter of next year (April to June). We will also start vaccinations for the general public at the same time, “he added, adding that” the moment of formation of group immunity will be similar to that of foreign countries or considerably faster. ”
Prime Minister Jeong Sye-gyun, who sat next to him, said: “We decided to introduce a vaccine for 46 million people, which is 2 million more than originally planned,” and said, “We will carefully prepare the amount of contracted vaccine to be vaccinated from the first quarter of next year “. These are statements that refute the point that the government’s vaccination war is relatively behind the United States and the United Kingdom. Prime Minister Chung said: “It is difficult to say definitively because it is affected by the production capacities of each pharmaceutical company” regarding the specific time of introduction of 46 million people.
There were also comments that were aware of the increase in public anxiety. Prime Minister Chung said: “After the diagnosis, we are solving a large part of the problem of waiting at home,” and Mr. Roh also explained that “the Disease Management Administration will soon inform the public about the current status of obtaining of vaccines and vaccination plans “. Chief Roh didn’t even skip the word “it’s still a model country for quarantine.” Additionally, the Democratic Party, the government, and the Blue House discussed ways to support Corona 19 damage, including the third disaster grant, and verified measures to secure quarantine and treatment facilities, and vaccination plans.
However, the opposition party continued to signal that “unfounded optimism.” Representative Joo criticized the perspectives of the government and the ruling party, saying, “There is a saying that if a ritual is performed with the mouth, the whole town will explode and die.” The government-insured AstraZeneca vaccine was removed as “a vaccine that has not been approved by the US Food and Drug Administration (FDA) and has not been approved in the United Kingdom, which is a developing country.”
‘Han-US Vaccine Swap’ was the first card I took out on this day. The hospital’s chief representative said: “It is urgent to secure the first vaccines through diplomatic consultations with the countries that have bought in abundance, not through contracts with the vaccine manufacturers. The vaccine exchange will be another security alliance ”. Like currency exchanges that exchange currencies at a predetermined exchange rate at a predetermined time, it is argued that an exchange agreement should be signed with the United States, such as receiving emergency vaccine supplies first and then reimbursing them with domestic vaccines. produced later.
The People’s Power emphasized that this exchange method is a proposal based on the Korea-United States Free Trade Agreement (FTA). During a press conference, Corona’s Countermeasures Security and Diplomacy Committee said: “In the ‘Pharmaceutical Products and Medical Devices’ section of Chapter 5 of the Korea-US FTA, content’ that promotes patent development was included high-quality and cloned drugs. ‘” We will deliver the vaccine exchange proposal to the US congressional think tank. “As Korea has more than 20% of the biosimilars (biogeneric drugs) production facilities in the world market, the public opinion is that it will not be fit. of a favorable vaccine.
Reporter Kim Hong-bum [email protected]
[ad_2]